🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Collegium Pharmaceutical, Inc.

COLL Healthcare
$35.81 $-1.99 (-5.26%)
Market Cap: $1.16 B
Gurus Holding
7
Popularity Rank
#1228
% of Shares Held
6.56%
Net Activity (Q4 2025)
-$4.71 M

Guru Ownership Trend

Guru Analysis for Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical, Inc. (COLL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $76.15 M.

Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.71 M net outflow during the quarter.

Recent activity highlights John Hussman who opened a new position. Conversely, Jefferies Group reduced exposure by 45.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$1.65 M
Total Buy Value
New Buys 0
Additions 4
-$6.36 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
4

FAQs for Collegium Pharmaceutical, Inc. (COLL)

Major holders include Renaissance Technologies (RenTech) ($74.88 M), Chuck Royce ($11.63 M), Cliff Asness ($4.69 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.13 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.71 M, with 4 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited COLL. The total reported sell value was $6.36 M.

Yes, 0 managers opened new positions in COLL, and 4 increased their existing holdings. The total reported buy value was $1.65 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.12% Add 1.1% 1,617,349 $74.88 M Q4 2025
0.12% Reduce -18.0% 251,153 $11.63 M Q4 2025
0.00% Add 16.1% 101,254 $4.69 M Q4 2025
0.75% New Buy 105,000 $3.47 M Q1 2026
0.01% Reduce -45.1% 24,300 $803,601 Q1 2026
0.00% Add 7.3% 17,176 $795,249 Q4 2025
0.00% Add 27.1% 10,404 $481,705 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form